On March 1, 2019, AMCP provided comments to CMS in response to its 2020 for Medicare Part D Call Letter. AMCP offered comments on the following sections of the notice; Part D Benefit Parameters for Non-Defined Standard Plans; Formulary Submissions; Medication Therapy Management (MTM); and Part D Mail Order Auto-Ship Modifications.
On February 12, 2019, AMCP provide comments to the HHS OCR in response to its Request for Information on Modifying HIPAA Rules to Improve Coordinated Care. AMCP shared its support of HIPAA modernization, specifically as it relates to aligning 42 CFR Part 2 requirements with HIPAA.